Embera NeuroTherapeutics is a development stage pharmaceutical company focused on developing treatments for smoking cessation and other addictions, for which there are a limited range of effective drug therapies or have no approved treatments. Embera is developing a novel addiction treatment (EMB-001) that targets specific and complementary brainfunctions that drive the craving and relapse associated with these disorders, an approach based on breakthrough discoveries of the scientific founder.

Biotechnology

Therapeutics

Embera NeuroTherapeutics

Embera NeuroTherapeutics' headquarters in Sudbury, MA, United States

Bob Linke

Gary Connor

Bruce McCarthy

Barbara S. Fox

Joseph F. Lovett

Carol A. Gloff

John B. Beaird

David Broecker

Ross P. Barrett

Douglas Feltner

Kathleen T. Brady

Jeffrey Ives

Nicholas E. Goeders

Thomas R. Kosten

Charles O’Brien

Theresa Winhusen

Rajita Sinha

Jed E. Rose

Description

People (1)

Carol A. Gloff

Jobs